semaglutide and non alcoholic fatty liver disease might be a key for breaking the vicious cycle of metabolically associated spectrum? Semaglutide 2·4 mg once weekly

You shouldn't take it if you're pregnant, breastfeeding, or planning a pregnancy in the next two months, or if you've had a serious allergic reaction to semaglutide

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related diseases.

The study also found no increased risk of hospitalization for diabetic ketoacidosis or severe hypoglycemia, supporting further randomized trials of GLP-1RAs as adjunctive therapy in type 1 diabetes.

Midlife has a way of sneaking up on you

Wegovy and Zepbound are popular weight loss injections used for chronic weight management in adults with obesity and overweight